These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Legacy effect of intensive glycaemic control in type 2 diabetes-the UKPDS. Rodriguez-Gutierrez R Lancet; 2024 Jul; 404(10448):100-102. PubMed ID: 39002982 [No Abstract] [Full Text] [Related]
3. Assessment of community-managed blood glucose control in patients with diabetes mellitus in Shenzhen, China. Fang L; Li Q; Ning J J Diabetes; 2024 Jul; 16(7):e13573. PubMed ID: 38923123 [No Abstract] [Full Text] [Related]
4. A comparative study of the effects of imeglimin add-on or metformin dose escalation on glycaemic variability in subjects with type 2 diabetes treated with low-dose metformin (MEGMI-CGM study). Takahashi A; Nomoto H; Onishi K; Manda S; Miya A; Kameda H; Nakamura A; Atsumi T Diabetes Obes Metab; 2024 Aug; 26(8):3471-3474. PubMed ID: 38699794 [No Abstract] [Full Text] [Related]
5. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy. Mukherjee JJ; Majumdar S; Ray S J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486 [No Abstract] [Full Text] [Related]
6. Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission? Popovic DS; Patoulias D; Koufakis T; Stavropoulos K; Karakasis P; Ruža I; Papanas N; Rizzo M; Doumas M J Diabetes Complications; 2024 Aug; 38(8):108800. PubMed ID: 38889536 [TBL] [Abstract][Full Text] [Related]
9. The glycaemic sixer [glycaemic hexad]. Kalra S J Pak Med Assoc; 2018 Oct; 68(10):1541-1542. PubMed ID: 30317360 [TBL] [Abstract][Full Text] [Related]
10. Response to Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570. Garvey WT; Cohen RM Diabetes Care; 2024 Sep; 47(9):e72-e73. PubMed ID: 39190926 [No Abstract] [Full Text] [Related]
11. Impact of Self-Monitoring Blood Glucose on Glycaemic Control Among Insulin-Treated Patients With Diabetes Mellitus in Northeastern Tanzania: A Randomised Controlled Trial. Muhali SS; Muhali FS; Mfinanga SG; Sadiq AM; Marandu AA; Kyala NJ; Said FH; Nziku EB; Mirai TE; Ngocho JS; Mlay HL; Waria GG; Chambega A; Kessy SN; Kilonzo KG; Lyamuya FS; Mkwizu EW; Shao ER; Chamba NG J Diabetes Res; 2024; 2024():6789672. PubMed ID: 38899147 [No Abstract] [Full Text] [Related]
12. Glycemic durability of monotherapy for diabetes. Parashar A; Varma A N Engl J Med; 2007 Mar; 356(13):1379; author reply 1380. PubMed ID: 17402164 [No Abstract] [Full Text] [Related]
13. The impact of GLP-1 receptor agonist shortages on glycaemic Control: Findings from an Australian specialist diabetes clinic. Nanayakkara N; Lh Huang M; Jenkins AJ; Cohen ND Diabetes Res Clin Pract; 2024 Jul; 213():111740. PubMed ID: 38852625 [TBL] [Abstract][Full Text] [Related]
14. Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients. Murase Y; Wakasugi T; Yagi K; Mabuchi H Diabetes Care; 2000 Jan; 23(1):131-2. PubMed ID: 10857989 [No Abstract] [Full Text] [Related]
15. Clinical practice. Glycemic management of type 2 diabetes mellitus. Ismail-Beigi F N Engl J Med; 2012 Apr; 366(14):1319-27. PubMed ID: 22475595 [No Abstract] [Full Text] [Related]
16. Glycaemic control in diabetes. Herman W Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678 [No Abstract] [Full Text] [Related]
17. Distinct trajectories of HbA Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW; Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761 [TBL] [Abstract][Full Text] [Related]
18. Glycaemic control in patients with diabetes and concomitant psoriasis. Shalom G; Shapiro J; Dreiher J; Nathan A; Freud T; Comaneshter D; Horev A; Khoury R; Vinker S; Cohen AD Br J Dermatol; 2016 Aug; 175(2):428-30. PubMed ID: 26991639 [No Abstract] [Full Text] [Related]